Click Here for 5% Off Your First Aladdin Purchase!

Name And Identifier

ID: ALA1766079

Max Phase: Preclinical

Molecular Formula: C13H8ClN3O2S

Molecular Weight: 305.75

Molecule Type: Small molecule

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

  1. Parent:

    ALA1766079

    ---

Molecule Features

Natural Product: NoChemical Probe: No
Molecule Type: Small moleculeFirst In Class: No
Chirality: NoProdrug: No
Oral: NoParenteral: No
Topical: NoBlack Box: No
Availability: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for Indication

Mechanisms of Action

Mechanism of ActionAction TypeTarget NameTarget TypeTarget OrganismBinding Site Name

Activity Summary

Bioactivity SummaryCount
EC501
Inhibition1
GI501
Assay SummaryCount
A-ADME1
F-Functional2

Properties

Molecular Weight: 305.75Molecular Weight (Monoisotopic): 305.0026
AlogP: 3.63#Rotatable Bonds: 3
Polar Surface Area: 68.88Molecular Species: NEUTRAL
HBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5
HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa:
CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: 3Heavy Atoms: 20
QED Weighted: 0.69Np Likeness Score: -1.71

References

1. Mayhoub AS, Khaliq M, Kuhn RJ, Cushman M..  (2011)  Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins.,  54  (6):   [PMID:21355607]

Source

Source(1):

  • Scientific Literature